Spero Therapeutics
SPRO
#9017
Rank
โ‚น6.02 B
Marketcap
โ‚น111.38
Share price
0.76%
Change (1 day)
20.46%
Change (1 year)

Spero Therapeutics (SPRO) - Cash on Hand

Cash on Hand as of June 2024 : โ‚น5.36 Billion

According to Spero Therapeutics's latest financial reports the company has โ‚น5.36 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Spero Therapeutics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น6.35 B-29.62%
2022-12-31โ‚น9.02 B-17.14%
2021-12-31โ‚น10.89 B17.41%
2020-12-31โ‚น9.28 B58.63%
2019-12-31โ‚น5.85 B-27.52%
2018-12-31โ‚น8.07 B44.83%
2017-12-31โ‚น5.57 B695.12%
2016-12-31โ‚น0.70 B85.34%
2015-12-31โ‚น0.37 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น3.08 B-42.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.156 T 21,468.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น150.61 B 2,709.83%๐Ÿ‡จ๐Ÿ‡ฆ Canada